Athenex DPO Ratio 2011-2026 | ATNX

Annual DPO Ratio Athenex

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
111	90.4	71.5	122	101	242	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
242	71.5	123

Quarterly DPO Ratio Athenex

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	41.2	-	61	-	77	82	95.3	92.6	69.5	51.6	97.9	136	125	126	83.3	83.1	99.1	126	119	151	188	367	383	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
383	41.2	126

DPO Ratio of other stocks in the Drug manufacturers industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	38	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	345	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	116	-	-	$ 754 M	USA
Avadel Pharmaceuticals plc AVDL	224	-	-	$ 2.06 B	France
Catalent CTLT	41.8	-	-	$ 11.5 B	USA
Agile Therapeutics AGRX	352	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	309	-	-	$ 142 M	USA
Eagle Pharmaceuticals EGRX	75.6	-	-39.89 %	$ 27.7 M	USA
DURECT Corporation DRRX	519	-	-	$ 50.1 M	USA
Evoke Pharma EVOK	5.36 K	-	-	$ 36.6 M	USA
Endo International plc ENDP	39.3	-	-	$ 28.9 M	Irlanda
Aurora Cannabis ACB	-807	$ 3.47	0.92 %	$ 86.3 M	Canada
Jupiter Wellness JUPW	318	-	-	$ 33.6 M	USA
Assertio Holdings ASRT	122	$ 19.37	0.83 %	$ 124 M	USA
Lannett Company LCI	36.8	-	1.15 %	$ 7.11 M	USA
Bausch Health Companies BHC	78.1	$ 5.38	0.56 %	$ 1.96 B	Canada
Canopy Growth Corporation CGC	52.8	$ 1.0	-0.18 %	$ 108 M	Canada
Cumberland Pharmaceuticals CPIX	775	$ 3.2	1.03 %	$ 45 M	USA
Cronos Group CRON	212	$ 2.56	1.1 %	$ 1.35 B	Canada
Emergent BioSolutions EBS	55.8	$ 8.23	-	$ 421 M	USA
Evolus EOLS	59.4	$ 4.14	2.61 %	$ 267 M	USA
Harrow Health HROW	199	$ 35.5	0.54 %	$ 1.3 B	USA
OptiNose OPTN	194	-	-	$ 1.08 B	USA
Organogenesis Holdings ORGO	94	$ 2.3	2.68 %	$ 303 M	USA
PetIQ PETQ	54.2	-	1.64 %	$ 400 M	USA
Pacira BioSciences PCRX	37.3	$ 22.49	-0.93 %	$ 1.04 B	USA
Rockwell Medical RMTI	15.4	$ 0.95	-0.73 %	$ 34.2 M	USA
SCYNEXIS SCYX	20.2	$ 0.94	5.86 %	$ 46.9 M	USA
ProPhase Labs PRPH	45.4	-	-	$ 5.07 M	USA
Radius Health RDUS	274	-	-	$ 1.42 B	USA
Sonoma Pharmaceuticals SNOA	32.3	$ 2.36	-0.42 %	$ 2.93 M	USA
Recro Pharma REPH	6.63	-	-4.76 %	$ 65.3 M	USA
Tilray TLRY	53	$ 6.61	0.84 %	$ 4.08 B	Canada
Veru VERU	264	$ 2.34	2.18 %	$ 316 M	USA
Viatris VTRS	64	$ 13.36	-0.6 %	$ 16 B	USA
cbdMD YCBD	84	$ 0.72	-1.17 %	$ 3.11 M	USA
Zomedica Corp. ZOM	64.3	-	-0.21 %	$ 98 M	USA
China Pharma Holdings CPHI	47.6	$ 0.61	-3.16 %	$ 2.62 M	China
TherapeuticsMD TXMD	723	$ 2.08	4.0 %	$ 24.1 M	USA